Hosted on MSN1mon
Johnson & Johnson Seeks FDA Approval to Expand TREMFYA® Use for Pediatric Conditions
SPRING HOUSE, PA — Johnson & Johnson has submitted two supplemental ... aiming to expand the use of TREMFYA® (guselkumab) for pediatric patients. The applications seek approval to treat ...
Finanznachrichten11mon
Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA (guselkumab)
Applications filed for TREMFYA ® to treat children with moderate to severe plaque psoriasis and active juvenile psoriatic arthritis SPRING HOUSE, Pa., Dec. 2, 2024 /PRNewswire/ -- Johnson ...